Show simple item record

dc.contributor.authorAbdelsalam Elshenawy, Rasha
dc.contributor.authorUmaru, Nikkie
dc.contributor.authorAslanpour, Zoe
dc.date.accessioned2024-09-11T14:05:16Z
dc.date.available2024-09-11T14:05:16Z
dc.date.issued2024-08-23
dc.identifier.citationAbdelsalam Elshenawy , R , Umaru , N & Aslanpour , Z 2024 , ' P11 Pharmacists’ knowledge, attitudes and perceptions towards antimicrobial stewardship and resistance during the COVID-19 pandemic at secondary care settings in the UK ' , JAC-Antimicrobial Resistance . https://doi.org/10.1093/jacamr/dlae136.015
dc.identifier.issn2632-1823
dc.identifier.otherORCID: /0000-0002-2567-0540/work/167438487
dc.identifier.otherORCID: /0000-0002-8954-0817/work/167438503
dc.identifier.urihttp://hdl.handle.net/2299/28167
dc.description© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/).
dc.description.abstractAddressing antimicrobial resistance (AMR) became critical during the COVID-19 pandemic, as inappropriate antibiotic prescribing worsened AMR. The WHO emphasized the need for antimicrobial stewardship (AMS), and the Royal Pharmaceutical Society underscored pharmacists’ roles in optimising antimicrobial use. Understanding pharmacists’ knowledge, attitudes, and perceptions (KAP) regarding antibiotic prescribing, AMR, and AMS is vital to enhancing global AMS efforts. To explore pharmacists’ KAP during the COVID-19 pandemic, a prospective cross-sectional study was conducted in 2023 using an online survey via Qualtrics, targeting registered pharmacists in a secondary care NHS Foundation Trust in the UK. The study received ethical approval, involved patient and public input, and was registered with ISRCTN and OCTOPUS. Most respondents were aged 25–31, female, and held postgraduate degrees. They demonstrated strong awareness of AMR and AMS, with the majority recognizing AMR as a public health concern and endorsing updated antibiotic guidelines. The study underscores pharmacists’ essential role in combating AMR, highlighting their potential to co-lead AMS initiatives and improve global health outcomes.en
dc.format.extent2
dc.format.extent96463
dc.language.isoeng
dc.relation.ispartofJAC-Antimicrobial Resistance
dc.subjectantimicrobial resistance (AMR)
dc.subjectantimicrobial resistance
dc.subjectantimicrobial stewardship (AMS)
dc.subjectAntimicrobial stewardship
dc.subjectAntimicrobial Stewardship
dc.subjectAntimicrobial stewardship competencies
dc.subjectAntimicrobial stewardship programmes
dc.subjectAntimicrobial stewardship programs
dc.subjectPharmacists
dc.subjectPharmacists role
dc.subjectPharmacists' role
dc.subjectcovid-19
dc.subjectCOVID-19 pandemic
dc.subjectCOVID-19/prevention & control
dc.subjectCOVID-19/epidemiology
dc.subjectCOVID-19/drug therapy
dc.subjectantibiotic prescribing
dc.subjectAntibiotic Prescribing
dc.subjectKnowledge, Attitudes, and Perceptions (KAP)
dc.subjectknowledge
dc.subjectattitudes
dc.subjectperceptions
dc.subjectPerceptions and attitudes
dc.subjectPublic health
dc.subjectPUBLIC HEALTH
dc.subjectPublic Health England
dc.subjectPublic Health Improvement
dc.subjectPublic health intervention
dc.subjectSecondary care
dc.subjectSecondary Care
dc.subjectAntibiotic Guidelines
dc.subjectAntibiotic awareness week
dc.subjectantibiotic classification
dc.subjectAntibiotic guardian
dc.subjectAntibiotic research
dc.subjectAntibiotic resistance
dc.subjectAntibiotic review
dc.subjectAntibiotic safety
dc.subjectantibiotic utilitsation
dc.subjectAntibiotics
dc.subjectGlobal Health Outcomes
dc.subjectGlobal Health
dc.subjectglobal health care
dc.subjectAcute care setting
dc.subjectacute care
dc.subjecthospital-acquired infections
dc.subjectHospitals
dc.subjectNHS
dc.subjectNHS Trust
dc.subjectUK Five-Year Action Plan
dc.titleP11 Pharmacists’ knowledge, attitudes and perceptions towards antimicrobial stewardship and resistance during the COVID-19 pandemic at secondary care settings in the UKen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionCentre for Future Societies Research
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1093/jacamr/dlae136.015
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record